Expect Afreeza to be Saved as an Alternative to Rapid-Acting Mealtime Insulin

You'll hear about Afrezza (uh-FREZ-uh), a new INHALED insulin for diabetes in adults.

It's now approved in the U.S...and possibly later in Canada.

The first inhaled insulin, Exubera, didn't pan out...partly because the inhaler was hard to use and was about the size of a tennis ball can.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote